# Characterizing mitochondrial phenotypes and MERCS in aged human skeletal muscle myoblasts

**Authors:** Yufu Unten, Kazuaki Takafuji, Yumiko Masukagami, Isshin Shiiba, Keigo Horiuchi, Filip Husnik, Shigeru Yanagi, Norifumi Tateishi, Toshihide Suzuki

PMC · DOI: 10.1371/journal.pone.0343604 · PLOS One · 2026-02-20

## TL;DR

This study explores how aging affects mitochondria in human muscle cells, finding that older cells show signs of aging and increased mitochondrial-ER connections.

## Contribution

The study reveals novel insights into mitochondrial hyperfusion and MERCS in aged human myoblasts and their link to oxidative stress.

## Key findings

- Older myoblasts show elevated senescence markers and mitochondrial oxidative stress.
- Mitochondrial hyperfusion and MERCS increase with age and are reduced by scavenging mtROS.
- Mitochondrial function remains stable despite structural changes in aged myoblasts.

## Abstract

Age-associated declines in skeletal muscle function are linked to cellular senescence and mitochondrial alterations, yet mitochondrial phenotypes in aged human myoblasts remain insufficiently characterized. Here, we examined primary skeletal muscle myoblasts from young and elderly donors to assess mitochondrial function, morphology, and mitochondria–endoplasmic reticulum (ER) contact sites (MERCS). Myoblasts from older donors exhibited senescence features, including elevated SA-β-gal activity and reduced Lamin B1 expression, accompanied by increased mitochondrial oxidative stress. Despite marked mitochondrial hyperfusion and increased mitochondrial DNA content, mitochondrial oxygen consumption rate and membrane potential per mitochondrial area were comparable between young and old cells. MERCS were significantly elevated in aged myoblasts and were reduced by scavenging mitochondrial reactive oxygen species (mtROS), indicating an association between oxidative stress and MERCS formation. These findings suggest that mitochondrial hyperfusion and enhanced MERCS accompany cellular aging in human myoblasts and may contribute to maintaining mitochondrial function under elevated oxidative stress.

## Linked entities

- **Genes:** Lam (Lamin) [NCBI Gene 33782]

## Full-text entities

- **Genes:** RPS20 (ribosomal protein S20) [NCBI Gene 6224] {aka S20, uS10}, Itpr1 (inositol 1,4,5-trisphosphate receptor 1) [NCBI Gene 16438] {aka D6Pas2, Gm10429, IP3R 1, IP3R1, InsP3R, Ip3r}, ND1 (NADH dehydrogenase subunit 1) [NCBI Gene 4535] {aka MTND1}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, ND5 (NADH dehydrogenase subunit 5) [NCBI Gene 4540] {aka MTND5}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, CYTB (cytochrome b) [NCBI Gene 4519] {aka MTCYB}, MFN1 (mitofusin 1) [NCBI Gene 55669] {aka hfzo1, hfzo2}, CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}, ALDH1A3 (aldehyde dehydrogenase 1 family member A3) [NCBI Gene 220] {aka ALDH1A6, ALDH6, MCOP8, RALDH3}, Tomm20 (translocase of outer mitochondrial membrane 20) [NCBI Gene 67952] {aka 1810060K07Rik, Gm19268, MAS20, MOM19, TOM20, mKIAA0016}, CRMP1 (collapsin response mediator protein 1) [NCBI Gene 1400] {aka CRMP-1, DPYSL1, DRP-1, DRP1, ULIP-3}, SPRY4 (sprouty RTK signaling antagonist 4) [NCBI Gene 81848] {aka HH17}, DDRGK1 (DDRGK domain containing 1) [NCBI Gene 65992] {aka C20orf116, SEMDSH, UFBP1, dJ1187M17.3}, GLB1 (galactosidase beta 1) [NCBI Gene 2720] {aka EBP, ELNR1, MPS4B}, LMNB1 (lamin B1) [NCBI Gene 4001] {aka ADLD, LMN, LMN2, LMNB, MCPH26}, Vdac1 (voltage-dependent anion channel 1) [NCBI Gene 22333] {aka Vdac5, mVDAC1, mVDAC5}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}
- **Diseases:** PLA (MESH:D014897), age-associated diseases (MESH:C564653), MERCS (MESH:D009371), decline in skeletal muscle function (MESH:D005207), nutritional deficiencies (MESH:D044342), mitochondrial decline (MESH:D028361), muscle (MESH:D019042), sarcopenia (MESH:D055948), inflammation (MESH:D007249), age-related diseases (MESH:D010024)
- **Chemicals:** lipid (MESH:D008055), cysteine (MESH:D003545), Paraformaldehyde (MESH:C003043), antimycin A (MESH:D000968), peptides (MESH:D010455), Resin (MESH:D012116), Agarose (MESH:D012685), H2O (MESH:D014867), glutamine (MESH:D005973), Duolink (MESH:C431350), DAPI (MESH:C007293), glucose (MESH:D005947), ethanol (MESH:D000431), formaldehyde (MESH:D005557), FCCP (MESH:D002259), calcium (MESH:D002118), ROS (MESH:D017382), Glycine (MESH:D005998), oligomycin (MESH:D009840), potassium ferrocyanide (MESH:C031835), PBS (MESH:D007854), oligonucleotides (MESH:D009841), glutaraldehyde (MESH:D005976), PVDF (MESH:C024865), SDS (MESH:D012967), Alexa Fluor 555 (MESH:C000608607), lead nitrate (MESH:C017461), formic acid (MESH:C030544), osmium tetroxide (MESH:D009993), oxygen (MESH:D010100), thiocarbohydrazide (MESH:C011368), silicon (MESH:D012825), C-23265 (-), methionine (MESH:D008715), phenol red (MESH:D010637), Agar (MESH:D000362), uranyl acetate (MESH:C005460), acetonitrile (MESH:C032159), acetone (MESH:D000096), Lipid peroxide (MESH:D008054), Lipofectamine (MESH:C086724), peroxide (MESH:D010545), aspartic acid (MESH:D001224), Mito-TEMPO (MESH:C555916), nitrogen (MESH:D009584), EDTA (MESH:D004492)
- **Species:** Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** hSKMC — Homo sapiens (Human), Transformed cell line (CVCL_VG48)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12923047/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12923047/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12923047/full.md

---
Source: https://tomesphere.com/paper/PMC12923047